Walleye Trading LLC - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 137 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 0.41 and the average weighting 0.3%.

Quarter-by-quarter ownership
Walleye Trading LLC ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,325,335
-23.8%
73,540
-1.7%
0.01%
-33.3%
Q2 2023$3,050,344
-14.1%
74,800
-21.5%
0.01%
+28.6%
Q1 2023$3,551,831
-19.6%
95,300
-24.7%
0.01%
-46.2%
Q4 2022$4,417,074
-32.1%
126,600
+8.9%
0.01%
-35.0%
Q3 2022$6,508,000
+80.7%
116,300
+67.1%
0.02%
+81.8%
Q2 2022$3,602,000
-27.5%
69,600
+1.8%
0.01%
-31.2%
Q1 2022$4,971,000
+13.6%
68,400
+84.9%
0.02%
+6.7%
Q4 2021$4,375,000
-40.5%
37,000
-32.5%
0.02%
-42.3%
Q3 2021$7,350,000
-10.2%
54,791
+8.4%
0.03%
-18.8%
Q2 2021$8,183,000
+274.7%
50,540
+85.8%
0.03%
+220.0%
Q1 2021$2,184,000
+308.2%
27,208
-25.3%
0.01%
+150.0%
Q4 2019$535,000
+276.8%
36,438
+243.8%
0.00%
+300.0%
Q3 2019$142,000
-81.7%
10,600
-76.6%
0.00%
-85.7%
Q1 2019$774,000
+32.3%
45,300
+5.7%
0.01%
+40.0%
Q4 2018$585,000
+145.8%
42,846
+416.2%
0.01%
+150.0%
Q3 2018$238,000
-89.3%
8,300
-89.8%
0.00%
-83.3%
Q2 2018$2,219,000
+281.9%
81,100
+194.4%
0.01%
+200.0%
Q1 2018$581,000
+122.6%
27,551
+104.1%
0.00%
+300.0%
Q4 2017$261,00013,5000.00%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Darwin Global Management, Ltd. 752,024$100,884,00018.57%
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 420,859$56,458,0004.40%
Discovery Value Fund 922,411$123,741,0003.63%
MPM BioImpact LLC 162,620$21,815,0003.38%
Ally Bridge Group (NY) LLC 65,000$8,720,0002.56%
ARK Investment Management 6,743,556$904,648,0002.17%
Integral Health Asset Management, LLC 50,000$6,708,0001.93%
Yorktown Management & Research Co Inc 18,300$2,455,0001.85%
Interchange Capital Partners, LLC 8,191$1,098,0001.84%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 111,440$14,950,0001.76%
View complete list of INTELLIA THERAPEUTICS INC shareholders